Intra-Cellular Therapies Overview
Intra-Cellular Therapies Discounted Cash Flow
DCF Analysis for ITCI.
Get informed when a big investor buys or sells
+ FollowFair Value
$69.66
Current Fair Value
$69.66
↓ 47.2% Downside
Overvalued by 47.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison